Sign Up
OverviewAPI
Bragar Eagel & Squire, P.C. initiates a class action lawsuit against Ventyx Biosciences, Inc. for alleged misleading statements on its clinical product candidate, VTX958, resulting in stock price decline and executive resignations.

Ask a question